These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
691 related articles for article (PubMed ID: 10336513)
1. MEN 11270, A novel selective constrained peptide antagonist with high affinity at the human B2 kinin receptor. Meini S; Quartara L; Rizzi A; Patacchini R; Cucchi P; Giolitti A; Calò G; Regoli D; Criscuoli M; Maggi CA J Pharmacol Exp Ther; 1999 Jun; 289(3):1250-6. PubMed ID: 10336513 [TBL] [Abstract][Full Text] [Related]
2. Effects of the non-peptide B2 antagonist FR173657 on kinin-induced smooth muscle contraction and relaxation, vasoconstriction and prostaglandin release. Griesbacher T; Sametz W; Legat FJ; Diethart S; Hammer S; Juan H Br J Pharmacol; 1997 Jun; 121(3):469-76. PubMed ID: 9179388 [TBL] [Abstract][Full Text] [Related]
3. Peptide and non-peptide bradykinin B2 receptor agonists and antagonists: a reappraisal of their pharmacology in the guinea-pig ileum. Meini S; Patacchini R; Lecci A; Quartara L; Maggi CA Eur J Pharmacol; 2000 Dec; 409(2):185-94. PubMed ID: 11104833 [TBL] [Abstract][Full Text] [Related]
4. MEN16132, a novel potent and selective nonpeptide antagonist for the human bradykinin B2 receptor. In vitro pharmacology and molecular characterization. Cucchi P; Meini S; Bressan A; Catalani C; Bellucci F; Santicioli P; Lecci A; Faiella A; Rotondaro L; Giuliani S; Giolitti A; Quartara L; Maggi CA Eur J Pharmacol; 2005 Dec; 528(1-3):7-16. PubMed ID: 16324696 [TBL] [Abstract][Full Text] [Related]
5. The N-terminal of icatibant and bradykinin interact with the same Asp residues in the human B2 receptor. Bellucci F; Meini S; Cucchi P; Catalani C; Giuliani S; Zappitelli S; Rotondaro L; Quartara L; Giolitti A; Maggi CA Eur J Pharmacol; 2004 May; 491(2-3):121-5. PubMed ID: 15140628 [TBL] [Abstract][Full Text] [Related]
6. The expression of functionally-coupled B2-bradykinin receptors in human corneal epithelial cells and their pharmacological characterization with agonists and antagonists. Wiernas TK; Griffin BW; Sharif NA Br J Pharmacol; 1997 Jun; 121(4):649-56. PubMed ID: 9208130 [TBL] [Abstract][Full Text] [Related]
7. Human vascular kinin receptors of the B2 type characterized by radioligand binding. Gessi S; Rizzi A; Calò G; Agnello G; Jorizzo G; Mollica G; Borea PA; Regoli D Br J Pharmacol; 1997 Dec; 122(7):1450-4. PubMed ID: 9421294 [TBL] [Abstract][Full Text] [Related]
8. Pharmacological characterization of the bradykinin B2 receptor: inter-species variability and dissociation between binding and functional responses. Paquet JL; Luccarini JM; Fouchet C; Defrêne E; Loillier B; Robert C; Bélichard P; Cremers B; Pruneau D Br J Pharmacol; 1999 Mar; 126(5):1083-90. PubMed ID: 10204994 [TBL] [Abstract][Full Text] [Related]
9. B1 and B2 kinin receptors on cultured rabbit superior mesenteric artery smooth muscle cells: receptor-specific stimulation of inositol phosphate formation and arachidonic acid release by des-Arg9-bradykinin and bradykinin. Tropea MM; Gummelt D; Herzig MS; Leeb-Lundberg LM J Pharmacol Exp Ther; 1993 Feb; 264(2):930-7. PubMed ID: 8382284 [TBL] [Abstract][Full Text] [Related]
10. Inflammation modifies the role of cyclooxygenases in the contractile responses of the rat detrusor smooth muscle to kinin agonists. Meini S; Lecci A; Cucchi P; Catalioto RM; Criscuoli M; Maggi CA J Pharmacol Exp Ther; 1998 Oct; 287(1):137-43. PubMed ID: 9765332 [TBL] [Abstract][Full Text] [Related]
11. LF 16.0335, a novel potent and selective nonpeptide antagonist of the human bradykinin B2 receptor. Pruneau D; Luccarini JM; Fouchet C; Defrêne E; Franck RM; Loillier B; Duclos H; Robert C; Cremers B; Bélichard P; Paquet JL Br J Pharmacol; 1998 Sep; 125(2):365-72. PubMed ID: 9786510 [TBL] [Abstract][Full Text] [Related]
12. Partial agonists and full antagonists at the human and murine bradykinin B1 receptors. MacNeil T; Feighner S; Hreniuk DL; Hess JF; Van der Ploeg LH Can J Physiol Pharmacol; 1997 Jun; 75(6):735-40. PubMed ID: 9276157 [TBL] [Abstract][Full Text] [Related]
13. Different B1 kinin receptor expression and pharmacology in endothelial cells of different origins and species. Wohlfart P; Dedio J; Wirth K; Schölkens BA; Wiemer G J Pharmacol Exp Ther; 1997 Feb; 280(2):1109-16. PubMed ID: 9023330 [TBL] [Abstract][Full Text] [Related]
14. High-affinity binding of peptide agonists to the human B1 bradykinin receptor depends on interaction between the peptide N-terminal L-lysine and the fourth extracellular domain of the receptor. Fathy DB; Kyle DJ; Leeb-Lundberg LM Mol Pharmacol; 2000 Jan; 57(1):171-9. PubMed ID: 10617692 [TBL] [Abstract][Full Text] [Related]
15. Differences between peptide and nonpeptide B(2) bradykinin receptor antagonists in blocking bronchoconstriction and hypotension induced by bradykinin in anesthetized Guinea pigs. Tramontana M; Lecci A; Meini S; Montserrat X; Pascual J; Giuliani S; Quartara L; Maggi CA J Pharmacol Exp Ther; 2001 Mar; 296(3):1051-7. PubMed ID: 11181940 [TBL] [Abstract][Full Text] [Related]
16. Characterization of the receptor and the mechanisms underlying the inflammatory response induced by des-Arg9-BK in mouse pleurisy. Vianna RM; Calixto JB Br J Pharmacol; 1998 Jan; 123(2):281-91. PubMed ID: 9489617 [TBL] [Abstract][Full Text] [Related]
17. The longitudinal muscle of rat ileum as a sensitive monoreceptor assay for bradykinin B1 receptors. Meini S; Lecci A; Maggi CA Br J Pharmacol; 1996 Apr; 117(8):1619-24. PubMed ID: 8732268 [TBL] [Abstract][Full Text] [Related]